Notice of availability to Registered Shareholders and Reply Form
Filed with HKEX · Stock code 512 · · 2 pages · English
Summary by 6ix AI
Grand Pharmaceutical Group Limited has issued a notice regarding the availability of corporate communications for registered shareholders. The notice informs shareholders about the electronic dissemination of future corporate communications and provides instructions for changing their preferred method of receipt. Shareholders are encouraged to provide their email addresses to ensure timely access to communications. The filing includes a reply form for shareholders to indicate their preferences for receiving future communications.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Grand Pharmaceutical Group Limited on 6ix
Earlier from Grand Pharmaceutical
- Notice of the special general meeting
- (1) Proposed change of auditors; and (2) notice of special general meeting
- Voluntary announcement: the international multi-center phase III clinical trial for the treatment of pterygium of the group's global innovative ophthalmic drug CBT-001 has reached its primary clinical endpoint
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
- Supplemental announcement in relation to proposed change of auditors
Follow Grand Pharmaceutical into a list and get an email when it puts out news.
Follow Grand Pharmaceutical